Search Results 11-20 of 16715 for GLP-1 agonists

  1. Management of obesity within hepatology clinics - Mayo Clinic

    Researchers discuss the role of dietary supplements, glucagon-like peptide 1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and bariatric ...

  2. Why gastroenterologists and hepatologists should be involved in treating obesity - Mayo Clinic

    Meta-analyses suggest that the GLP-1 agents SQ semaglutide and liraglutide perform well in this role. GLP-1 agonists are associated with an increased risk ...

  3. Contribution of GLP-1 Receptor - Mayo Clinic

    The GLP-1 receptor gene is found on the beta cells of the pancreas. Its role is in the control of blood sugar level by enhancing insulin secretion from the ...

  4. Semaglutide (oral route) - Side effects & dosage - Mayo Clinic

    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide is also used together with diet and exercise to help lose weight and keep the ...

  5. Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in Type 1 and Type 2 Diabetes - Mayo Clinic

    Prior use of GLP-1 receptor agonists in the previous year. Active systemic illness or malignancy. Symptomatic macrovascular or microvascular disease. Note ...

  6. Tradipitant After GLP-1R Agonist In Healthy, Overweight, or Class I or II Obese Volunteers - Mayo Clinic

    The purpose of this study is to evaluate the effect of tradipitant relative to placebo on proportion of subjects with at least 1 vomiting episode per week ...

  7. Diabetes treatment: Medications for type 2 diabetes - Mayo Clinic

    Tirzepatide (Mounjaro), a similar kind of medicine called a dual-acting GLP-1/GIP agonist. Action. Cause the release of insulin as blood sugar levels are rising ...

  8. Tirzepatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    ... glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide injection is ... It is not safe for one pen to be used for more than one person. Sharing ...

  9. Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists - Mayo Clinic

    Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists ... GLP1-RAs. Participation eligibility. Participant ...

  10. Liraglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    This medicine is a glucagon-like peptide-1 (GLP-1) receptor agonist. Liraglutide injection is also used together with a reduced-calorie diet and proper exercise ...